Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet

被引:90
作者
Murakami, S [1 ]
Kondo-Ohta, Y [1 ]
Tomisawa, K [1 ]
机构
[1] Taisho Pharmaceut Co Ltd, Med Res Labs, Ohmiya, Saitama 3308530, Japan
关键词
taurine; cholesterol; atherosclerosis; C57BL/6J mice;
D O I
10.1016/S0024-3205(98)00536-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
The effects of chronic treatment of taurine can hypercholesterolemia and atherosclerosis were examined in C57BL/6J mice fed a high-fat diet containing 15% fat and 1.25% cholesterol. Taurine was dissolved in drinking water at 1% (whv) and was given to mice ad libitum during 6 months-feeding of a high-fat diet. Hypercholesterolemia occurred and lipid accumulation on the aortic valve was evident. Taurine treatment lowered serum LDL + VLDL cholesterol by 44% in mice fed a high-fat diet, while it elevated serum HDL cholesterol by 25%. As a result, the atherogenic index, the ratio of HDL to LDL + VLDL was markedly improved. Cholesterol content in the liver also decreased by 19% with taurine. Similar tendencies were seen in mice fed regular chow, but the changes were not significant. The area of aortic lipid accumulation, which served as an index of atherosclerosis, was reduced by 20% with taurine. In the liver, taurine doubled the activity of cholesterol 7 alpha-hydoxylase. These observations, together with prior findings, suggest that the cholesterol-lowering action of taurine may relate to the increased conversion of cholesterol to bile acids via stimulation of cholesterol 7 alpha-hydroxylase activity. Thus, chronic treatment of high-fat mice with taurine improves the abnormal profile of the serum lipoproteins, and thereby retards the progression of atherosclerosis.
引用
收藏
页码:83 / 91
页数:9
相关论文
共 40 条
[1]
GENETIC VARIATIONS IN SERUM-LIPID LEVELS OF INBRED MICE AND RESPONSE TO HYPERCHOLESTEROLEMIC DIET [J].
AUBERT, R ;
PERDEREAU, D ;
ROUBISCOUL, M ;
HERZOG, J ;
LEMONNIER, D .
LIPIDS, 1988, 23 (01) :48-54
[2]
BELLENTANI S, 1987, J LIPID RES, V28, P1021
[3]
BROWN MS, 1979, J BIOL CHEM, V254, P5144
[4]
EFFECT OF PARTIAL ILEAL BYPASS-SURGERY ON MORTALITY AND MORBIDITY FROM CORONARY HEART-DISEASE IN PATIENTS WITH HYPERCHOLESTEROLEMIA - REPORT OF THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERLIPIDEMIAS (POSCH) [J].
BUCHWALD, H ;
VARCO, RL ;
MATTS, JP ;
LONG, JM ;
FITCH, LL ;
CAMPBELL, GS ;
PEARCE, MB ;
YELLIN, AE ;
EDMISTON, WA ;
SMINK, RD ;
SAWIN, HS ;
CAMPOS, CT ;
HANSEN, BJ ;
TUNA, N ;
KARNEGIS, JN ;
SANMARCO, ME ;
AMPLATZ, K ;
CASTANEDAZUNIGA, WR ;
HUNTER, DW ;
BISSETT, JK ;
WEBER, FJ ;
STEVENSON, JW ;
LEON, AS ;
CHALMERS, TC .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :946-955
[5]
CARR TP, 1989, P SOC EXP BIOL MED, V191, P370, DOI 10.3181/00379727-191-42935
[6]
EFFECT OF DIETARY-FAT SATURATION ON PLASMA-LIPOPROTEINS AND HIGH-DENSITY-LIPOPROTEIN METABOLISM OF THE RHESUS-MONKEY [J].
CHONG, KS ;
NICOLOSI, RJ ;
RODGER, RF ;
ARRIGO, DA ;
YUAN, RW ;
MACKEY, JJ ;
GEORAS, S ;
HERBERT, PN .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :675-683
[7]
Dueland S, 1997, J LIPID RES, V38, P1445
[8]
BILE-ACID SEQUESTRANTS - MECHANISMS OF ACTION ON BILE-ACID AND CHOLESTEROL-METABOLISM [J].
EINARSSON, K ;
ERICSSON, S ;
EWERTH, S ;
REIHNER, E ;
RUDLING, M ;
STAHLBERG, D ;
ANGELIN, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 :S53-S58
[9]
EMESON EE, 1993, AM J PATHOL, V142, P1906
[10]
HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND CARDIOVASCULAR-DISEASE - 4 PROSPECTIVE AMERICAN-STUDIES [J].
GORDON, DJ ;
PROBSTFIELD, JL ;
GARRISON, RJ ;
NEATON, JD ;
CASTELLI, WP ;
KNOKE, JD ;
JACOBS, DR ;
BANGDIWALA, S ;
TYROLER, HA .
CIRCULATION, 1989, 79 (01) :8-15